Skip to content
Riskpilot
← Back to search
Sign in
Get full access
NORSK MEDISINSK SYKLOTRONSENTER AS
AS
Active
Org 986358692
Ullernchausséen 64, 0379
Oslo
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2004
54 employees
www.syklotronsenteret.no
Watchlist
Share
Norway
/
Companies
/
Manufacture of pharmaceutical preparations
/
NORSK MEDISINSK SYKLOTRONSENTER AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
TA
Thor Audun Saga
Chief Executive Officer
Chief Executive Officer
2011
AD
Andreas Drangevåg
Observer
Observer
2024
KH
Karoline Hartvig
Deputy Member
Deputy Member
2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (7)
GE
Glenn Egil Ruud
Deputy Chairman
2024
PB
Paulina Bakema Due-Tønnessen
Board of Directors
2022
JP
Janne Pedersen
Board of Directors
2022
BF
Bjørn Fuglaas
Chairman
2024
AM
Abelone Martilla Tislevoll
Board of Directors
2024
JD
Jo Døhl
Board of Directors
2022
EE
Eivor Eugenie Hellstrøm Hoddevik Hernes
Board of Directors
2022
Former (6)
PO
Per Oscar Bremer
Board of Directors
2020 – 2022
IP
Ingar Pettersen
Chairman
2022 – 2023
KM
Kjell Magne Tveit
Deputy Chairman
2020 – 2022
PD
Paulina Due-Tønnessen
Board of Directors
2022 – 2023
JJ
Jørgen Jansen
Chairman
2023 – 2024
AT
Anne Toril Aalvik
Board of Directors
2022 – 2024
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Oslo Universitetssykehus Hf
Company
70%
70%
2024
Universitetet I Oslo
Company
20%
20%
2024
Akershus Universitetssykehus Hf
Company
10%
10%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on NORSK MEDISINSK SYKLOTRONSENTER AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
